Monthly Issue

1996 - Volume 22

Volume 22-24, 15 December 1996

• Childhood pertussis immunization status as reported by parents and the completeness of public-health and physician records in Nova Scotia
• Notifiable Diseases Summary

Volume 22-23, 1 December 1996

• Influenza in Canada - 1995-1996 season
• Enterohemorrhagic Escherichia coli infection - Japan

Volume 22-22, 15 November 1996

• 1995-1996 influenza season: Canadian laboratory diagnoses and strain characterization
• Antigenic analysis of recent influenza virus isolates and influenza activity in the southern hemisphere
• Surveillance for Creutzfeldt-Jakob Disease - United States
• Creutzfeldt-Jakob Disease - Switzerland
• Announcement

Volume 22-21, 1 November 1996

• Immunization survey of non-institutionalized adults - Quebec (as of May 30, 1996)
• Adult immunization survey - Ottawa, 1996
• Botulism in Canada - Summary for 1995
• Botulism reference service for Canada

Volume 22-20, 15 October 1996

• Fatal falciparum malaria in Canadian travellers
• Malaria-boundary health unit, British Columbia, 1995
• Request for research proposals
• World malaria situation in 1993

Volume 22-19, 1 October 1996

• Penicillin resistance among invasive pneumococcal isolates at 10 children's hospitals, 1991-1994
• Streptococcus pneumoniae with reduced susceptibility to Penicillin G - British Columbia
• Notifiable Diseases Summary

Volume 22-18, 15 September 1996

• CATMAT - tuberculosis screening and the international traveller
• Survey of vancomycin-resistant enterococci in the fraser valley of British Columbia

Volume 22-17, 1 September 1996

• CATMAT & NACI - Travel, influenza, and prevention
• Progress towards the elimination of leprosy as a public health problem
• Advisory notice: Infection control for Creutzfeldt-Jakob Disease

Volume 22-16, 15 August 1996

• Resurgence of hepatitis a in homosexual men in Montreal Centre, Quebec
• Isolation of Borrelia burgdorferi - Thunder Bay district, Ontario
• Notifiable Diseases Summary

Volume 22-15, 1 August 1996

• Emergence of Neisseria gonorrhoeae strains with decreased susceptibility to ciprofloxacin - Quebec, 1994-1995
• Vancomycin-resistant enterococci on a renal ward in an Ontario hospital
• Invasive infection due to Streptococcus iniae: a new or previously unrecognized disease - Ontario, 1995-1996

Volume 22-14, 15 July 1996

• NACI supplementary statement-mmr vaccine and anaphylactic hypersensitivity to egg or egg-related antigens
• NACI - interim advisory on measles revaccination of persons with Acquired Immunodeficiency Syndrome (AIDS)
• The safety of immune globulins
• Salmonella typhimurium infections in humans - United Kingdom
• Reminder

Volume 22-13, 1 July 1996

• CATMAT - Statement on motion sickness
• Scientific consultation on human and animal spongiform encephalopathies

Volume 22-12, 15 June 1996

• NACI-statement on influenza vaccination for the 1996-97 season
• Hantavirus Pulmonary Syndrome - United States, 1995 and 1996

Volume 22-11, 1 June 1996

• Summary of the national consensus conference on foodborne, waterborne and enteric disease surveillance
• Ebola-reston virus infection among quarantined nonhuman primates - United States, 1996
• Outbreak of Ebola hemorrhagic fever in gabon officially declared over
• Progress towards poliomyelitis eradication
• Notifiable Diseases Summary

Volume 22-10, 15 May 1996

• CATMAT and NACI - preliminary conjoint statement on oral cholera vaccination
• Cholera in British Columbia
• Cholera in Africa
• New variant of Creutzfeldt-Jakob Disease (V-CJD)-France
• Announcement

Volume 22-9, 1 May 1996

• National mycology strategic planning workshop
• Notice
• Erratum
• Announcements
• Clarifications

Volume 22-8, 15 April 1996

• Creutzfeldt-Jakob Disease in Canada
• A gastroenteritis outbreak among Canadian tourists in Mexico
• Announcement

Volume 22-7, 1 April 1996

• Evidence for TB clustering in Vancouver: results from pilot study using RFLP fingerprinting
• National surveillance of occupational exposure to the human immunodeficiency virus
• Protocols help protect against getting HIV-but you have to use them

Volume 22-6, 15 March 1996

• A household cluster of fulminant group a streptococcus pneumonia associated with toxic shock syndrome - Quebec
• Strategies for preventing early onset group B streptococcal infection
• Respiratory syncytial virus in Canada

Volume 22-5, 1 March 1996

• Survey of congenital rubella syndrome, Montreal, laval, and montérégie, Quebec, 1985-1991
• Surveillance of congenital rubella syndrome and other rubella- associated adverse pregnancy outcomes
• Survey of postpartum rubella vaccination, montreal, laval, and montérégie, Quebec, 1992

Volume 22-4, 15 February 1996

• CATMAT - Travel medicine recommendation: dengue fever and international travel
• Dengue in the Americas
• Preliminary report: biosafety analysis of one-way backflow valves for multiple patient use of low osmolar intravenous contrast solution
• Updated advisory notice: low osmolar dye intravenous delivery systems

Volume 22-3, 1 February 1996

• Failures after immunization with haemophilus influenzae type b vaccines - 1991-1995
• Respiratory virus surveillance, winter 1995-1996 - Canada
• Notifiable diseases summary

Volume 22-2, 15 January 1996

• NACI - Supplementary statement on measles elimination in Canada
• Brucellosis associated with unpasteurized milk products abroad - United Kingdom

Volume 22-1, 1 January 1996

• NACI - Supplementary statement on hepatitis a prevention
• Arbovirus surveillance - United States
• Influenza surveillance worldwide
• Antigenic analysis of recent influenza virus isolates and influenza activity in the southern hemisphere
• Notifiable Diseases Summary

Advisory Committee Statements and Supplements to the CCDR

Guidelines for Preventing the Transmission of Tuberculosis in Canadian Health Care Facilities and Other Institutional Settings CCDR Supplement Volume 21S1, April 1996

Information on how to download PDF files

Canada Communicable Disease Report Masthead

Guidelines for Authors Contributing to the CCDR

CCDR Author's Checklist